The impact of COVID-19 restrictions on HIV prevention and treatment services for key populations in South Africa: an interrupted time series analysis.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 12 01 2024
accepted: 02 08 2024
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 2 9 2024
Statut: epublish

Résumé

Key populations (KP), including men who have sex with men (MSM), female sex workers (FSW), and transgender women (TGW), experience a disproportionate burden of HIV, even in generalized epidemics like South Africa. Given this disproportionate burden and unique barriers to accessing health services, sustained provision of care is particularly relevant. It is unclear how the COVID-19 pandemic and its associated restrictions may have impacted this delivery. In this study, we aimed to describe patterns of engagement in HIV prevention and treatment services among KP in South Africa and assess the impact of different COVID-19 restriction levels on service delivery. We leveraged programmatic data collected by the US President's Emergency Plan for AIDS Relief (PEPFAR)-supported KP partners in South Africa. We divided data into three discrete time periods based on national COVID-19 restriction periods: (i) Pre-restriction period, (ii) High-level restriction period, and (iii) After-high level restriction period. Primary outcomes included monthly total HIV tests, new HIV cases identified, new initiations of pre-exposure prophylaxis (PrEP), and new enrollments in antiretroviral therapy (ART). We conducted interrupted time series segmented regression analyses to estimate the impact of COVID-19 restrictions on HIV prevention and treatment service utilization. Between January 2018 and June 2022, there were a total of 231,086 HIV tests, 27,051 HIV positive cases, 27,656 pre-exposure prophylaxis (PrEP) initiations, and 15,949 antiretroviral therapy initiations among MSM, FSW and TGW in PEPFAR-supported KP programs in South Africa. We recorded 90,457 total HIV tests during the 'pre-restriction' period, with 13,593 confirmed new HIV diagnoses; 26,134 total HIV tests with 2,771 new diagnoses during the 'high-level restriction' period; and 114,495 HIV tests with 10,687 new diagnoses during the after high-level restriction period. Our Poisson regression model estimates indicate an immediate and significant decrease in service engagement at the onset of COVID-19 restrictions, including declines in HIV testing, treatment, and PrEP use, which persisted. As programs adjusted to the new restrictions, there was a gradual rebound in service engagement, particularly among MSM and FSW. Towards the end of the high-level restriction period, with some aspects of daily life returning to normal but others still restricted, there was more variability. Some indicators continued to improve, while others stagnated or decreased. Service provision rebounded from the initial shock created by pandemic-related restrictions, and HIV services were largely maintained for KP in South Africa. These results suggest that HIV service delivery among programs designed for KP was able to be flexible and resilient to the evolving restrictions. The results of this study can inform plans for future pandemics and large-scale disruptions to the delivery of HIV services.

Sections du résumé

BACKGROUND BACKGROUND
Key populations (KP), including men who have sex with men (MSM), female sex workers (FSW), and transgender women (TGW), experience a disproportionate burden of HIV, even in generalized epidemics like South Africa. Given this disproportionate burden and unique barriers to accessing health services, sustained provision of care is particularly relevant. It is unclear how the COVID-19 pandemic and its associated restrictions may have impacted this delivery. In this study, we aimed to describe patterns of engagement in HIV prevention and treatment services among KP in South Africa and assess the impact of different COVID-19 restriction levels on service delivery.
METHODS METHODS
We leveraged programmatic data collected by the US President's Emergency Plan for AIDS Relief (PEPFAR)-supported KP partners in South Africa. We divided data into three discrete time periods based on national COVID-19 restriction periods: (i) Pre-restriction period, (ii) High-level restriction period, and (iii) After-high level restriction period. Primary outcomes included monthly total HIV tests, new HIV cases identified, new initiations of pre-exposure prophylaxis (PrEP), and new enrollments in antiretroviral therapy (ART). We conducted interrupted time series segmented regression analyses to estimate the impact of COVID-19 restrictions on HIV prevention and treatment service utilization.
RESULTS RESULTS
Between January 2018 and June 2022, there were a total of 231,086 HIV tests, 27,051 HIV positive cases, 27,656 pre-exposure prophylaxis (PrEP) initiations, and 15,949 antiretroviral therapy initiations among MSM, FSW and TGW in PEPFAR-supported KP programs in South Africa. We recorded 90,457 total HIV tests during the 'pre-restriction' period, with 13,593 confirmed new HIV diagnoses; 26,134 total HIV tests with 2,771 new diagnoses during the 'high-level restriction' period; and 114,495 HIV tests with 10,687 new diagnoses during the after high-level restriction period. Our Poisson regression model estimates indicate an immediate and significant decrease in service engagement at the onset of COVID-19 restrictions, including declines in HIV testing, treatment, and PrEP use, which persisted. As programs adjusted to the new restrictions, there was a gradual rebound in service engagement, particularly among MSM and FSW. Towards the end of the high-level restriction period, with some aspects of daily life returning to normal but others still restricted, there was more variability. Some indicators continued to improve, while others stagnated or decreased.
CONCLUSION CONCLUSIONS
Service provision rebounded from the initial shock created by pandemic-related restrictions, and HIV services were largely maintained for KP in South Africa. These results suggest that HIV service delivery among programs designed for KP was able to be flexible and resilient to the evolving restrictions. The results of this study can inform plans for future pandemics and large-scale disruptions to the delivery of HIV services.

Identifiants

pubmed: 39223515
doi: 10.1186/s12889-024-19679-0
pii: 10.1186/s12889-024-19679-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2386

Informations de copyright

© 2024. The Author(s).

Références

Sharif N, Alzahrani KJ, Ahmed SN, et al. Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022. PLoS ONE. 2022;17:1–24.
doi: 10.1371/journal.pone.0271074
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5)533–4.
Baral S, Rao A, Rwema JOT, et al. Competing health risks associated with the COVID-19 pandemic and early response: a scoping review. PLoS ONE. 2022;17(8):e0273389.
Rao A, Rucinski K, Jarrett BA, et al. Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries. J Acquir Immune Defic Syndr. 1988;2021:87.
de Villiers C, Cerbone D, Van Zijl W. The South African government’s response to COVID-19. J Public Budg Account Financ Manag. 2020;32. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3750437 .
Jensen C, McKerrow NH. Child health services during a COVID-19 outbreak in KwaZulu-Natal Province, South Africa. S Afr Med J. 2020;0(0):13185.
Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7(5):e308–9.
Zuma K, Simbayi L, Zungu N, et al. The HIV epidemic in South Africa: key findings from 2017 national population-based survey. Int J Environ Res Public Health 2022;19.
Thembisa Project. Origin of the Thembisa model. https://www.thembisa.org/about# . (2 April 2023, date last accessed).
Oni T, Mayosi BM. Mortality trends in South Africa: progress in the shadow of HIV/AIDS and apartheid. Lancet Glob Health. 2016;4:e588–9.
doi: 10.1016/S2214-109X(16)30178-4 pubmed: 27539796
Sabin K, Zhao J, Garcia Calleja JM, et al. Availability and quality of size estimations of female sex workers, men who have sex with men, people who inject drugs and transgender women in low- and middle-income countries. PLoS One. 2016;11(5):e0155150.
Iversen J, Sabin K, Chang J, et al. COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses. J Int AIDS Soc. 2020;23(10):e25632.
Delany-Moretlwe S, Cowan FM, Busza J, Bolton-Moore C, Kelley K, Fairlie L. Providing comprehensive health services for young key populations: needs, barriers and gaps. J Int AIDS Soc. 2015;18(2 Suppl 1):19833.
Belay YA, Yitayal M, Atnafu A, Taye FA. Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: a scoping review. BMC Health Serv Res. 2022;22:1–23.
doi: 10.1186/s12913-022-08825-2
Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Res Ther. 2021;18(1):28.
Gomez GB, Eakle R, Mbogua J, Akpomiemie G, Venter WDF, Rees H. Treatment and prevention for female Sex workers in South Africa: protocol for the TAPS demonstration project. BMJ Open. 2016;6(9):e011595.
Hugo JM, Rebe KB, Tsouroulis E, et al. Anova Health Institute’s harm reduction initiatives for people who use drugs. Sex Health. 2018;15(2):176–8.
Chiliza, Jessica Brennan, T Alana, Laing R. Evaluation of the impact of PEPFAR transition on retention in care in South Africa’s Western Cape. medRxiv. 2023;01. Preprint.
Govt. USA. PEPFAR Announces New $100 Million Investment Fund to Expand Access to Proven HIV Prevention and Treatment Services for Key Populations. 2016. https://reliefweb.int/report/world/pepfar-announces-new-100-million-investment-fund-expand-access-proven-hiv-prevention . (5 March 2023, date last accessed).
Wits RHI. No Title. https://www.wrhi.ac.za/ . (2 April 1BC, date last accessed).
OUT LGBT Well-being. OUT’s EMH tackles treatment challenges with specialist HIV doctor. https://out.org.za/outs-emh-tackles-treatment-challenges-with-specialist-hiv-doctor-2/ . # (2 April 2023, date last accessed).
fhi360. Standardized DHIS 2 Tracker Metadata Package for HIV Programs. https://www.fhi360.org/resources/standardized-dhis-2-tracker-metadata-package-hiv-programs/ . 2021.
Government. SA. About alert system. https://www.gov.za/covid-19/about/about-alert-system . 2020.
Berk R, MacDonald JM. Overdispersion and poisson regression. J Quant Criminol. 2008;24:269–84.
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–55.
Bottomley C, Scott JAG, Isham V. Analysing interrupted time series with a control. Epidemiol Methods. 2019;8(1):20180010.
Zeileis A. Econometric computing with HC and HAC covariance matrix estimators. J Stat Softw. 2004;11(1).
Stolwijk AM, Straatman H, Zielhuis GA. Studying seasonality by using sine and cosine functions in regression analysis. J Epidemiol Community Health. 1978;1999:53.
Dorward J, Khubone T, Gate K, et al. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. Lancet HIV. 2021;8(3):e158–65.
Davey DLJ, Bekker LG, Mashele N, Gorbach P, Coates TJ, Myer L. PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa. Lancet HIV. 2020;7(11):e735.
Pillay Y, Pienaar S, Barron P, Zondi T. Impact of COVID-19 on routine primary healthcare services in South Africa. S Afr Med J. 2021;111(8):714–9.
Leigh S. The Multiplying Threats Facing Sex Workers Today. Open society foundations 2020. https://www.opensocietyfoundations.org/voices/the-multiplying-threats-facing-sex-workers-today . (5 March 2023, date last accessed).
Bachanas PJ, Chun HM, Mehta N, et al. Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19. J Int AIDS Soc. 2022;25:1–12.
doi: 10.1002/jia2.26033

Auteurs

Danwei Yao (D)

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, USA.

Naomi Hill (N)

Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.

Ben Brown (B)

Anova Health Institute, Cape Town, South Africa.

Dorian Gule (D)

OUT LGBT Well-Being, Johannesburg, South Africa.

Matshidiso Chabane (M)

Aurum Institute, Johannesburg, South Africa.

Mfezi Mcingana (M)

TB HIV Care, Cape Town, South Africa.

Kalai Willis (K)

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, USA.

Vusi Shiba (V)

Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.

Oluwasolape Olawore (O)

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, USA.

Dawie Nel (D)

OUT LGBT Well-Being, Johannesburg, South Africa.

Jacqueline Pienaar (J)

Aurum Institute, Johannesburg, South Africa.

Johanna Theunissen (J)

Panagora Group, Silver Spring, USA.

Katherine Rucinski (K)

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, USA.
Department of International Health, Johns Hopkins School of Public Health, Baltimore, USA.

Katie Reichert (K)

Panagora Group, Silver Spring, USA.

Lauren Parmley (L)

USAID/Southern Africa, Bilateral Health Office, Pretoria, South Africa.

J Joseph Lawrence (JJ)

USAID/Southern Africa, Bilateral Health Office, Pretoria, South Africa.

Stefan Baral (S)

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, USA.

Amrita Rao (A)

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, USA. arao24@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH